Literature DB >> 6377111

Immunohistochemical demonstration of amyloid P component in cerebro-vascular amyloidosis.

I F Rowe, O Jensson, P D Lewis, J Candy, G A Tennent, M B Pepys.   

Abstract

The presence of amyloid P component (AP) in cerebral amyloid deposits was sought using a direct immunoperoxidase technique. AP was detected in the amyloid deposits in the vessel walls but was absent from the intracerebral plaques in tissue from patients with senile cerebral amyloidosis. AP was also present in the amyloid deposits in the vessel walls of patients with the Icelandic form of hereditary cerebral haemorrhage associated with amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377111     DOI: 10.1111/j.1365-2990.1984.tb00340.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  9 in total

1.  Amyloid arthropathy.

Authors:  I F Rowe
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

2.  Immunodetection of the amyloid P component in Alzheimer's disease.

Authors:  T Duong; E C Pommier; A B Scheibel
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  A new method to classify amyloid fibril proteins.

Authors:  T Kitamoto; J Tateishi; K Hikita; H Nagara; I Takeshita
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

4.  Amyloid-P-component-like immunoreactivity in beta/A4-immunoreactive deposits in Alzheimer-type dementia brains.

Authors:  M Kimura; H Arai; T Takahashi; N Iwamoto
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

5.  Circulating serum amyloid P component is the precursor of amyloid P component in tissue amyloid deposits.

Authors:  M L Baltz; D Caspi; D J Evans; I F Rowe; C R Hind; M B Pepys
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

6.  Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis.

Authors:  G T Westermark; B Norling; P Westermark
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

7.  Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.

Authors:  P N Hawkins; M J Myers; A A Epenetos; D Caspi; M B Pepys
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

Review 8.  Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology.

Authors:  M Mahafuzur Rahman; Christofer Lendel
Journal:  Mol Neurodegener       Date:  2021-08-28       Impact factor: 14.195

9.  Pharmacological removal of serum amyloid P component from intracerebral plaques and cerebrovascular Aβ amyloid deposits in vivo.

Authors:  Raya Al-Shawi; Glenys A Tennent; David J Millar; Angela Richard-Londt; Sebastian Brandner; David J Werring; J Paul Simons; Mark B Pepys
Journal:  Open Biol       Date:  2016-02       Impact factor: 6.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.